19-2434061-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_032737.4(LMNB2):c.1247G>A(p.Arg416Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000751 in 1,598,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNB2 | ENST00000325327.4 | c.1247G>A | p.Arg416Gln | missense_variant | Exon 8 of 12 | 1 | NM_032737.4 | ENSP00000327054.3 | ||
LMNB2 | ENST00000490554.5 | n.438G>A | non_coding_transcript_exon_variant | Exon 3 of 4 | 2 | |||||
LMNB2 | ENST00000532465.1 | n.-162G>A | upstream_gene_variant | 3 | ||||||
LMNB2 | ENST00000527409.1 | n.*234G>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000915 AC: 2AN: 218582Hom.: 0 AF XY: 0.0000167 AC XY: 2AN XY: 119990
GnomAD4 exome AF: 0.00000691 AC: 10AN: 1446634Hom.: 0 Cov.: 36 AF XY: 0.00000835 AC XY: 6AN XY: 718732
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
Lipodystrophy, partial, acquired, susceptibility to;C4225289:Progressive myoclonic epilepsy type 9 Uncertain:1
This sequence change replaces arginine with glutamine at codon 416 of the LMNB2 protein (p.Arg416Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs200293412, ExAC 0.008%). This variant has not been reported in the literature in individuals with LMNB2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at